EU close to approving Siemens Healthineers $16b Varian acquisition

  • European Union antitrust regulators are close to giving conditional approved to Siemens Healthineers (OTC:SEMHF) $16b acquisition of Varian Medical Systems Medical (NYSE:VAR), according a Reuters report.
  • The EU antitrust regulator's greenlight comes after Siemens offered last month to address the regulator's competition issues around interoperability, Reuters said, citing people familiar.
  • The EU regulator's deadline to make a decision is Friday, February 19th.

    Fundamentals Siemens Healthineers

    Over the current book year the total revenue will be 15.66 billion euros (consensus estimates). This is slightly more than 2019's revenue of 14.46 billion euros.

    Historical revenues and results Siemens Healthineers plus estimates 2020


    The analysts expect for 2020 a net profit of 1.84 billion euros. For this year the consensus of Siemens Healthineers 's result per share is a profit of 1.69 euros. So the price/earnings-ratio equals 28.03.

    Per share the analysts are expecting a dividend of 90 cents per share. Thus the dividend yield equals 1.9 percent. The average dividend yield of the health care companies equals a moderate 0.17 percent.

    Siemens Healthineers 's market capitalization is around 47.34 billion euros. The Siemens Healthineers stock was the past 12 months quite unstable. Since last February the stock is 20 percent higher. This year the stock price moved between 29 and 50 euro.

    Historical stock prices Siemens Healthineers period 2007-2020

    financial analysis siemenshealthineers

    Click here for dividend Siemens Healthineers. At 17.35 the stock trades 0.63 percent lower at 47.37 euros. Nieuwsdienst: +31 084-0032-842

    Copyright B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.